Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?
- PMID: 30673921
- DOI: 10.1007/s11154-018-9478-8
Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?
Erratum in
-
Correction to: Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?Rev Endocr Metab Disord. 2019 Jun;20(2):251-252. doi: 10.1007/s11154-019-09493-0. Rev Endocr Metab Disord. 2019. PMID: 30903391
Abstract
The immune system is closely intertwined with the endocrine system. Many effects of medications used for various clinical endocrine conditions such as the metabolic syndrome, hypercholesterolemia, diabetes mellitus, hypertension, Graves' disease and others also have an impact on the immune system. Some drugs including statins, metformin, angiotensin converting enzyme and proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones are known to have immunomodulatory properties. We here review the literature on this topic and provide some clinical examples including the use of statins in Graves' orbitopathy, rheumatoid arthritis, multiple sclerosis, and adult-onset Still's disease. In that context, we introduce a special immunodiagnostics method developed at the Institute of Diabetes "Gerhardt Katsch" in Karlsburg, Germany, to not only measure but also monitor immune disease activity.
Keywords: Autoantigen; Autoimmune; Flow cytometry; Immune; Interleukin 2; Lupus; Metformin; Multiple sclerosis; Orbitopathy; PCSK9; Rheumatoid arthritis; Somatostatin; Statin; Testosterone; Thyroid.
Similar articles
-
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications.Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):44-53. doi: 10.1093/ehjcvp/pvv045. Epub 2015 Nov 29. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533061 Review.
-
Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report.Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1647-50. doi: 10.1161/ATVBAHA.116.307493. Epub 2016 Apr 14. Arterioscler Thromb Vasc Biol. 2016. PMID: 27079874
-
The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins.Curr Pharm Des. 2017;23(10):1477-1483. doi: 10.2174/1381612823666170125154257. Curr Pharm Des. 2017. PMID: 28128061 Review.
-
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition with Bococizumab on Lipoprotein Particles in Hypercholesterolemic Subjects.Clin Ther. 2017 Nov;39(11):2243-2259.e5. doi: 10.1016/j.clinthera.2017.09.009. Epub 2017 Oct 14. Clin Ther. 2017. PMID: 29037448
-
Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association.J Clin Lipidol. 2017 Jul-Aug;11(4):891-900. doi: 10.1016/j.jacl.2017.04.120. Epub 2017 May 24. J Clin Lipidol. 2017. PMID: 28550993
Cited by
-
Influence of lipid-lowering drugs on inflammation: what is yet to be done?Arch Med Sci. 2021 Mar 20;18(4):855-869. doi: 10.5114/aoms/133936. eCollection 2022. Arch Med Sci. 2021. PMID: 35832698 Free PMC article.
-
Evolocumab prevents atrial fibrillation in rheumatoid arthritis rats through restraint of PCSK9 induced atrial remodeling.J Adv Res. 2024 Jul;61:211-221. doi: 10.1016/j.jare.2023.09.007. Epub 2023 Sep 12. J Adv Res. 2024. PMID: 37709197 Free PMC article.
-
Preventing Thyroid Eye Disease with Statins: Evidence from a Meta-Analysis.Cureus. 2025 May 19;17(5):e84388. doi: 10.7759/cureus.84388. eCollection 2025 May. Cureus. 2025. PMID: 40395707 Free PMC article. Review.
-
Immunoendocrinology: When (neuro)endocrinology and immunology meet.Rev Endocr Metab Disord. 2018 Dec;19(4):277-282. doi: 10.1007/s11154-018-9479-7. Rev Endocr Metab Disord. 2018. PMID: 30656554 No abstract available.
-
Nuclear receptors, cholesterol homeostasis and the immune system.J Steroid Biochem Mol Biol. 2019 Jul;191:105364. doi: 10.1016/j.jsbmb.2019.04.013. Epub 2019 Apr 16. J Steroid Biochem Mol Biol. 2019. PMID: 31002862 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous